X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (22) 22
female (21) 21
breast cancer (18) 18
oncology (16) 16
breast neoplasms - drug therapy (14) 14
adult (13) 13
cancer (13) 13
middle aged (12) 12
aged (10) 10
aged, 80 and over (9) 9
breast neoplasms - pathology (9) 9
hematology, oncology and palliative medicine (8) 8
analysis (7) 7
chemotherapy (7) 7
treatment outcome (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
randomized-trial (6) 6
retrospective studies (6) 6
survival (6) 6
antineoplastic agents - therapeutic use (5) 5
metastasis (5) 5
adjuvant chemotherapy (4) 4
disease-free survival (4) 4
docetaxel (4) 4
follow-up studies (4) 4
hematology (4) 4
melanoma (4) 4
metastases (4) 4
prognosis (4) 4
receptor, erbb-2 - metabolism (4) 4
therapy (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - adverse effects (3) 3
aromatase inhibitors (3) 3
bevacizumab - therapeutic use (3) 3
braf (3) 3
breast neoplasms - diagnosis (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - mortality (3) 3
cancer patients (3) 3
cell biology (3) 3
chemotherapy, adjuvant (3) 3
endocrine therapy (3) 3
first-line therapy (3) 3
letrozole (3) 3
metastatic breast cancer (3) 3
neoplasm staging (3) 3
neoplasms (3) 3
ovarian reserve (3) 3
paclitaxel (3) 3
phase-iii trial (3) 3
postmenopausal women (3) 3
relapse (3) 3
research (3) 3
research paper (3) 3
risk factors (3) 3
skin (3) 3
survival rate (3) 3
trastuzumab (3) 3
trastuzumab - therapeutic use (3) 3
women (3) 3
adjuvant endocrine therapy (2) 2
adjuvant trastuzumab (2) 2
adolescent (2) 2
amenorrhea - chemically induced (2) 2
anastrozole (2) 2
animals (2) 2
anti-mullerian hormone (2) 2
anti-müllerian hormone (2) 2
antimullerian hormone (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
aromatase inhibitors - adverse effects (2) 2
aromatase inhibitors - therapeutic use (2) 2
benign (2) 2
bevacizumab (2) 2
body mass index (2) 2
breast - pathology (2) 2
breast neoplasms - blood (2) 2
breast neoplasms - metabolism (2) 2
capecitabine (2) 2
care and treatment (2) 2
child (2) 2
classification (2) 2
clinical-practice (2) 2
cohort studies (2) 2
combination (2) 2
deoxyribonucleic acid--dna (2) 2
development and progression (2) 2
drug therapy (2) 2
efficacy (2) 2
endocrine resistance (2) 2
endothelial growth-factor (2) 2
epidermal growth factor (2) 2
erbb-2 protein (2) 2
estrogen (2) 2
expression (2) 2
genetic polymorphisms (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular Physiology, ISSN 0021-9541, 06/2019, Volume 234, Issue 6, pp. 7708 - 7717
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2017, Volume 111, pp. 31 - 38
Highlights • LncRNAs transcript large part of the non-coding information of the human DNA. • They are involved in several peri-trascriptional cell networks and... 
Hematology, Oncology and Palliative Medicine | Oncogenesis | Oncosuppressor | CASC2 | lncRNA | Cancer | Animals | Endometrial Neoplasms - genetics | Humans | Tumor Suppressor Proteins - genetics | Female | RNA, Long Noncoding - genetics | Genes, Tumor Suppressor | RNA
Journal Article
JOURNAL OF TRANSLATIONAL MEDICINE, ISSN 1479-5876, 08/2019, Volume 17, Issue 1, pp. 289 - 10
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2014, Volume 147, Issue 3, pp. 599 - 607
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2017, Volume 232, Issue 6, pp. 1571 - 1578
Journal Article
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2019
We analyzed data from 738 HER2-positive metastatic breast cancer (mbc) patients treated with pertuzumab-based regimens and/or T-DM1 at 45 Italian centers.... 
Journal Article
BMC PULMONARY MEDICINE, ISSN 1471-2466, 11/2019, Volume 19, Issue 1, pp. 1 - 10
Background Lung cancer is one of the most incident neoplastic diseases, and a leading cause of death for cancer worldwide. Knowledge of the incidence of... 
Adenocarcinoma | Targeted therapies | ALK | ED AMERICAN-COLLEGE | Lung cancer | CLINICAL CHARACTERISTICS | BRAF | KINASE INHIBITORS | EGFR | FEATURES | CANCER DIAGNOSIS | RESPIRATORY SYSTEM | cMET | MOLECULAR EPIDEMIOLOGY | NEVER SMOKERS | KRAS | RECEPTOR GENE | MUTATIONS | MET
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 9, pp. 8531 - 8541
Cutaneous melanoma is a common and aggressive human skin cancers. Much is actually known about the molecular mechanisms underlying melanoma pathogenesis. The... 
Oncogenic driver genes | Fluorescence in situ hybridization (FISH) analysis | Mutation analysis | Genetic heterogeneity | Malignant melanoma
Journal Article
Journal Article